Additionally, Ppara, a nuclear receptor participating in the development of hepatic steatosis induced by TCS [21], was up-regulated after TCS treatment in LSEC_mid2, Hep3, aHSC1 and KC_M2 cells in our study. The gene discussed is PPARA; the disease is Hepatic steatosis.